Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine for postoperative delirium and depression in older cardiac or major vascular surgery patients
ACTRN12615001074583Phase 4Completed
- Sponsor
- St Vincent's Hospital
- Start
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of ketamine in major depressive disorder (MDD), delirium and post-operative cognitive decline (POCD) (2 arms), sponsored by St Vincent's Hospital. Primary endpoints: Incidence of delirium and Incidence of depression. Started Jun 2015; status: completed.
02
Drugs
ketamine
03
Conditions
major depressive disorder (MDD)deliriumpost-operative cognitive decline (POCD)
Beyond the preview
Go deeper on ACTRN12615001074583.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12615001074583.